Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Spironolactone plus finasteride reduces hirsutism more effectively.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Rice bran extract might help prevent hair loss.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

The document concludes that more research is needed to fully understand the causes of PCOS.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.